Results 31 to 40 of about 48,868 (199)
Background This paper highlights the issues that one of the 90 Italian Research Ethics Committees (RECs) might encounter during the approval phase of a clinical trial to identify corrective and preventive actions for promoting a more efficient review ...
G. Benfatto +3 more
doaj +1 more source
Pharmacovigilance during mass immunization campaign with MenAfrivac τm in Cameroon [PDF]
Background. Immunization is one of the most cost effective public health interventions and is estimated to have greatly reduced diseases, disabilities, deaths, and inequities worldwide.
Ateudjieu, Jerome
core +1 more source
The risk of preterm labor after COVID-19 vaccination before and during pregnancy
Background: Pregnant women have a higher risk of severe illness and adverse pregnancy outcomes due to a SARS-CoV-2 infection. COVID-19 vaccination can prevent (severe) infection.
M. de Feijter +5 more
doaj +1 more source
Background Cefaclor, a second-generation oral cephalosporin, is widely prescribed to treat infectious diseases. Immediate hypersensitivity (HS) reactions to cefaclor have continuously been reported and are expected to increase with its greater use.
Hyo-In Rhyou +8 more
doaj +1 more source
Designing adverse event forms for real-world reporting: participatory research in Uganda. [PDF]
The wide-scale roll-out of artemisinin combination therapies (ACTs) for the treatment of malaria should be accompanied by continued surveillance of their safety.
Clare I R Chandler +37 more
core +2 more sources
An amendment to this paper has been published and can be accessed via the original article.
G. Benfatto +3 more
doaj +1 more source
Medication errors safety signals COVID-19-related Moroccan Pv database [PDF]
On March 23, 2020, the Moroccan Ministry of Health issued a circular authorizing the off label use of hydroxychloroquine or chloroquine in combination with azythromycin as first-line treatment for all COVID-19 patients. The aim of this study is to detect,
Sefiani Houda +3 more
doaj +1 more source
Background Dolutegravir (DTG) is an Integrase Strand Transfer Inhibitor (INSTI) indicated in combination with other antiretroviral agents for the treatment of HIV infection.
Alemayehu L. Duga +5 more
doaj +1 more source
Hospital doctors' views and concerns about pharmacovigilance [PDF]
Purpose: The aim of the study was to evaluate the opinions and concerns of hospital doctors about adverse drug reactions (ADRs) and pharmacovigilance.
Pedrós, Consuelo +7 more
core +1 more source
Vaccination process evaluation at COVID-19 vaccination centers in Lebanon: a national study
Background Upon the authorization of COVID-19 vaccines worldwide, national and international standards were developed to help integrate mass COVID-19 immunization campaigns into the healthcare network.
Abeer Zeitoun +7 more
doaj +1 more source

